Journal article
RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts
PloS one, Vol.8(11), pp.e80228-e80228
2013
DOI: 10.1371/journal.pone.0080228
PMCID: PMC3839920
PMID: 24282525
Abstract
RABL6A (RAB-like 6 isoform A) is a novel protein that was originally identified based on its association with the Alternative Reading Frame (ARF) tumor suppressor. ARF acts through multiple p53-dependent and p53-independent pathways to prevent cancer. How RABL6A functions, to what extent it depends on ARF and p53 activity, and its importance in normal cell biology are entirely unknown. We examined the biological consequences of RABL6A silencing in primary mouse embryo fibroblasts (MEFs) that express or lack ARF, p53 or both proteins. We found that RABL6A depletion caused centrosome amplification, aneuploidy and multinucleation in MEFs regardless of ARF and p53 status. The centrosome amplification in RABL6A depleted p53-/- MEFs resulted from centrosome reduplication via Cdk2-mediated hyperphosphorylation of nucleophosmin (NPM) at threonine-199. Thus, RABL6A prevents centrosome amplification through an ARF/p53-independent mechanism that restricts NPM-T199 phosphorylation. These findings demonstrate an essential role for RABL6A in centrosome regulation and maintenance of chromosome stability in non-transformed cells, key processes that ensure genomic integrity and prevent tumorigenesis.
Details
- Title: Subtitle
- RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts
- Creators
- Xuefeng Zhang - Department of Pharmacology, University of Iowa, Iowa City, Iowa, United States of AmericaJussara HagenViviane P MunizTarik SmithGary S CoombsChristine M EischenDuncan I MackieDavid L RomanRichard Van RheedenBenjamin DarbroVan S TompkinsDawn E Quelle
- Resource Type
- Journal article
- Publication Details
- PloS one, Vol.8(11), pp.e80228-e80228
- DOI
- 10.1371/journal.pone.0080228
- PMID
- 24282525
- PMCID
- PMC3839920
- NLM abbreviation
- PLoS One
- ISSN
- 1932-6203
- eISSN
- 1932-6203
- Publisher
- Public Library of Science; United States
- Grant note
- R21 CA127031 / NCI NIH HHS CA090367 / NCI NIH HHS CA127031 / NCI NIH HHS R01 CA090367 / NCI NIH HHS
- Language
- English
- Date published
- 2013
- Academic Unit
- Pharmacy; Molecular Physiology and Biophysics; Stead Family Department of Pediatrics; Pathology; Iowa Neuroscience Institute; Pharmaceutical Sciences and Experimental Therapeutics; Medical Genetics and Genomics; Neuroscience and Pharmacology; Biochemistry and Molecular Biology; Medicinal and Natural Products Chemistry
- Record Identifier
- 9984040281502771
Metrics
20 Record Views